119 related articles for article (PubMed ID: 18178638)
1. Is CHEK2 a cause of the Li-Fraumeni syndrome?
Evans DG; Birch JM; Narod SA
J Med Genet; 2008 Jan; 45(1):63-4. PubMed ID: 18178638
[No Abstract] [Full Text] [Related]
2. Increasing evidence that germline mutations in CHEK2 do not cause Li-Fraumeni syndrome.
Sodha N; Houlston RS; Bullock S; Yuille MA; Chu C; Turner G; Eeles RA
Hum Mutat; 2002 Dec; 20(6):460-2. PubMed ID: 12442270
[No Abstract] [Full Text] [Related]
3. The CHEK2 gene and inherited breast cancer susceptibility.
Nevanlinna H; Bartek J
Oncogene; 2006 Sep; 25(43):5912-9. PubMed ID: 16998506
[TBL] [Abstract][Full Text] [Related]
4. BRCA2: a cause of Li-Fraumeni-like syndrome.
Evans DG; Wu CL; Birch JM
J Med Genet; 2008 Jan; 45(1):62-3. PubMed ID: 18178637
[No Abstract] [Full Text] [Related]
5. Li-Fraumeni syndrome: the genetics and treatment considerations for the sarcoma and associated neoplasms.
Upton B; Chu Q; Li BD
Surg Oncol Clin N Am; 2009 Jan; 18(1):145-56, ix. PubMed ID: 19056046
[TBL] [Abstract][Full Text] [Related]
6. [Li-Fraumeni syndrome].
Tsunematsu Y
Nihon Rinsho; 2000 Jul; 58(7):1442-7. PubMed ID: 10921321
[TBL] [Abstract][Full Text] [Related]
7. Genetic mapping of a third Li-Fraumeni syndrome predisposition locus to human chromosome 1q23.
Bachinski LL; Olufemi SE; Zhou X; Wu CC; Yip L; Shete S; Lozano G; Amos CI; Strong LC; Krahe R
Cancer Res; 2005 Jan; 65(2):427-31. PubMed ID: 15695383
[TBL] [Abstract][Full Text] [Related]
8. Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome.
Bell DW; Varley JM; Szydlo TE; Kang DH; Wahrer DC; Shannon KE; Lubratovich M; Verselis SJ; Isselbacher KJ; Fraumeni JF; Birch JM; Li FP; Garber JE; Haber DA
Science; 1999 Dec; 286(5449):2528-31. PubMed ID: 10617473
[TBL] [Abstract][Full Text] [Related]
9. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family.
Sherif ZA; Danielsen M
Cancer Genet Cytogenet; 2006 Jul; 168(1):50-8. PubMed ID: 16772121
[TBL] [Abstract][Full Text] [Related]
10. [Tumor diseases in families of 600 breast cancer patients with special reference to familial adenocarcinomatosis and the Li-Fraumeni-/SBLA syndrome].
Müller H; Mosimann S; Gebhardt M; Scott R; Spycher M; Weber W
Helv Chir Acta; 1992 May; 59(1):239-45. PubMed ID: 1526835
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing and mutation status of CHEK2 in stage III breast cancer.
Staalesen V; Falck J; Geisler S; Bartkova J; Børresen-Dale AL; Lukas J; Lillehaug JR; Bartek J; Lønning PE
Oncogene; 2004 Nov; 23(52):8535-44. PubMed ID: 15361853
[TBL] [Abstract][Full Text] [Related]
12. Destabilization of CHK2 by a missense mutation associated with Li-Fraumeni Syndrome.
Lee SB; Kim SH; Bell DW; Wahrer DC; Schiripo TA; Jorczak MM; Sgroi DC; Garber JE; Li FP; Nichols KE; Varley JM; Godwin AK; Shannon KM; Harlow E; Haber DA
Cancer Res; 2001 Nov; 61(22):8062-7. PubMed ID: 11719428
[TBL] [Abstract][Full Text] [Related]
13. Li-Fraumeni syndrome.
Birch JM
Eur J Cancer; 1994; 30A(13):1935-41. PubMed ID: 7734204
[No Abstract] [Full Text] [Related]
14. Germline TP53 R337H mutation is not sufficient to establish Li-Fraumeni or Li-Fraumeni-like syndrome.
Ribeiro RC; Rodriguez-Galindo C; Figueiredo BC; Mastellaro MJ; West AN; Kriwacki R; Zambetti GP
Cancer Lett; 2007 Mar; 247(2):353-5; author reply 356-8. PubMed ID: 16750598
[No Abstract] [Full Text] [Related]
15. TP53, hChk2, and the Li-Fraumeni syndrome.
Varley J
Methods Mol Biol; 2003; 222():117-29. PubMed ID: 12710683
[TBL] [Abstract][Full Text] [Related]
16. [Li-Fraumeni syndrome].
Frebourg T
Bull Cancer; 1997 Jul; 84(7):735-40. PubMed ID: 9339200
[TBL] [Abstract][Full Text] [Related]
17. Li-Fraumeni syndrome in pediatric patients with soft tissue sarcoma or osteosarcoma.
Carnevale A; Lieberman E; Cárdenas R
Arch Med Res; 1997; 28(3):383-6. PubMed ID: 9291635
[TBL] [Abstract][Full Text] [Related]
18. [A report of a family affected by a Li-Fraumeni type of syndrome with adrenal cortical carcinoma in an adult. A case].
Massotti G; Tonolini M; Saibene F; Gattoni F; Uslenghi CM
Radiol Med; 2000 Mar; 99(3):206-9. PubMed ID: 10879177
[No Abstract] [Full Text] [Related]
19. TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes.
Ruijs MW; Verhoef S; Rookus MA; Pruntel R; van der Hout AH; Hogervorst FB; Kluijt I; Sijmons RH; Aalfs CM; Wagner A; Ausems MG; Hoogerbrugge N; van Asperen CJ; Gomez Garcia EB; Meijers-Heijboer H; Ten Kate LP; Menko FH; van 't Veer LJ
J Med Genet; 2010 Jun; 47(6):421-8. PubMed ID: 20522432
[TBL] [Abstract][Full Text] [Related]
20. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
Frebourg T; Abel A; Bonaiti-Pellie C; Brugières L; Berthet P; Bressac-de Paillerets B; Chevrier A; Chompret A; Cohen-Haguenauer O; Delattre O; Feingold J; Feunteun J; Frappaz D; Fricker JP; Gesta P; Jonveaux P; Kalifa C; Lasset C; Leheup B; Limacher JM; Longy M; Nogues C; Oppenheim D; Sommelet D; Soubrier F; Stoll C; Stoppa-Lyonnet D; Tristant H
Bull Cancer; 2001 Jun; 88(6):581-7. PubMed ID: 11459705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
